4593.T Stock - Healios K.K.
Unlock GoAI Insights for 4593.T
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $560.00M | $121.00M | $90.00M | $41.00M | $27.00M |
| Gross Profit | $432.00M | $108.00M | $90.00M | $41.00M | $27.00M |
| Gross Margin | 77.1% | 89.3% | 100.0% | 100.0% | 100.0% |
| Operating Income | $-2,902,000,000 | $-3,379,000,000 | $-5,179,000,000 | $-5,384,000,000 | $-4,184,000,000 |
| Net Income | $-4,235,000,000 | $-3,823,000,000 | $-5,170,000,000 | $-4,912,000,000 | $-5,513,000,000 |
| Net Margin | -756.3% | -3159.5% | -5744.4% | -11980.5% | -20418.5% |
| EPS | $-47.87 | $-56.22 | $-90.69 | $-93.40 | $-107.21 |
Healios K.K. engages in the research and development, manufacture, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States. The company is also developing cellular and tissue-based products comprising HLCR011 and HLCR012 that are iPSC regenerative medicines for the treatment of age-related macular degeneration; HLCL041, an iPSC regenerative medicine for the treatment of metabolic liver disease; and HLCM051, a regenerative medicine for treatment of ischemic stroke and acute respiratory distress syndrome, as well as HLCN061 for treating solid tumors. Healios K.K. has a joint research agreement with the Hyogo Medical University on cancer immunotherapies for mesothelioma using eNK cells. The company was formerly known as Retina Institute Japan, K.K. and changed its name to Healios K.K. in September 2013. Healios K.K. was incorporated in 2011 and is headquartered in Tokyo, Japan.
Visit WebsiteEarnings History & Surprises
4593.TEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 13, 2025 | $6.37 | $4.88 | -23.4% | ✗ MISS |
Q2 2025 | May 13, 2025 | $-29.05 | $-26.72 | +8.0% | ✓ BEAT |
Q1 2025 | Feb 12, 2025 | $-11.63 | $2.84 | +124.4% | ✓ BEAT |
Q4 2024 | Nov 13, 2024 | $-11.63 | $-17.00 | -46.2% | ✗ MISS |
Q3 2024 | Aug 13, 2024 | $9.63 | $-5.92 | -161.5% | ✗ MISS |
Q2 2024 | May 13, 2024 | $-4.96 | $-29.05 | -485.7% | ✗ MISS |
Q1 2024 | Feb 14, 2024 | $-14.63 | $-23.20 | -58.6% | ✗ MISS |
Q4 2023 | Nov 14, 2023 | $-13.62 | $-9.97 | +26.8% | ✓ BEAT |
Q3 2023 | Aug 14, 2023 | $-15.94 | $-10.37 | +34.9% | ✓ BEAT |
Q2 2023 | May 12, 2023 | $-13.29 | $-11.52 | +13.3% | ✓ BEAT |
Q1 2023 | Feb 14, 2023 | $4.04 | $-19.54 | -583.7% | ✗ MISS |
Q4 2022 | Nov 14, 2022 | $-12.42 | $-12.30 | +1.0% | ✓ BEAT |
Q3 2022 | Aug 9, 2022 | $-1.54 | $-32.64 | -2019.5% | ✗ MISS |
Q2 2022 | May 10, 2022 | $-10.97 | $-26.48 | -141.4% | ✗ MISS |
Q1 2022 | Feb 14, 2022 | $-49.21 | $-22.04 | +55.2% | ✓ BEAT |
Q4 2021 | Nov 12, 2021 | $-28.93 | $-34.78 | -20.2% | ✗ MISS |
Q3 2021 | Aug 10, 2021 | $-41.63 | $-16.68 | +59.9% | ✓ BEAT |
Q2 2021 | May 14, 2021 | $-25.94 | $-19.92 | +23.2% | ✓ BEAT |
Q1 2021 | Feb 12, 2021 | — | $-29.02 | — | — |
Q4 2020 | Nov 13, 2020 | — | $-27.35 | — | — |
Latest News
Frequently Asked Questions about 4593.T
What is 4593.T's current stock price?
What is the analyst price target for 4593.T?
What sector is Healios K.K. in?
What is 4593.T's market cap?
Does 4593.T pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to 4593.T for comparison